Professional Documents
Culture Documents
AVELOX
AVELOX
DELSTRIGO™ (doravirine and lamivudine and tenofovir disoproxil fumarate) Tablet for
Oral UseDoravirine / Lamivudine / Tenofovir Disoproxil Fumarate Bilayer Formulation
DIAZOXIDE (diazoxide) Capsules 100mgDiazoxide (>30%) Formulation
DIAZOXIDE (diazoxide) Capsules 25mgDiazoxide (<15%) Formulation
DIFICID® (fidaxomicin) for Oral SuspensionFidaxomicin Solid Formulation
DIFICID® (fidaxomicin) TabletsFidaxomicin Formulation
EFFICIB® (sitagliptin and metformin) Tablet for Oral UseSitagliptin / Metformin Formulation
EMEND COMBI PACK® (aprepitant) Capsules for Oral SuspensionAprepitant Formulation
EMEND TRI-PACK® (aprepitant) Capsules for Oral SuspensionAprepitant Formulation
EMEND® (aprepitant) Capsules for Oral SuspensionAprepitant Formulation
EMEND® (fosaprepitant) for Injection, for Intravenous UseFosaprepitant Formulation
ENTEREG® (alvimopan) Capsules, for Oral UseAlvimopan Formulation
ERELSA® (elbasvir) Tablet for Oral UseElbasvir Formulation
ESMERON® (rocuronium bromide) Solution for InjectionRocuronium Bromide Formulation
K
KEYTRUDA® (pembrolizumab) Concentrate for Solution for InfusionPembrolizumab Liquid
Formulation
KEYTRUDA® (pembrolizumab) Injection, for Intravenous UsePembrolizumab Liquid
Formulation
KEYTRUDA® (pembrolizumab) Powder for Concentrate for Solution for
InfusionPembrolizumab Solid Formulation
KEYTRUDA® (pembrolizumab) Powder for Injection, for Intravenous UsePembrolizumab
Solid Formulation
NIMEGON MET® (sitagliptin and metformin) Tablet for Oral UseSitagliptin / Metformin
Formulation
NIMEGON® (sitagliptin) Tablets for Oral UseSitagliptin Formulation
NOXAFIL® (posaconazole) Delayed-Release TabletsPosaconazole Solid Formulation
NOXAFIL® (posaconazole) Injection, for Intravenous UsePosaconazole Injection
Formulation
NOXAFIL® (posaconazole) Oral SuspensionPosaconazole Suspension Formulation
S
SAFLUTAN® (tafluprost) Eye Drop SolutionTafluprost Formulation
SEGLUROMET™ (ertugliflozin and metformin) TabletsErtugliflozin / Metformin Formulation
SIMPONI® (golimumab) Pre-Filled PenGolimumab Formulation
SIMPONI® (golimumab) Solution for InjectionGolimumab Formulation
SIVEXTRO® (tedizolid phosphate) for Injection, for Intravenous UseTedizolid Injection
Formulation
SIVEXTRO® (tedizolid phosphate) Powder for Concentrate for Solution for
InfusionTedizolid Injection Formulation
SIVEXTRO® (tedizolid phosphate) Tablets, for Oral UseTedizolid Solid Formulation
SPRIAFIL® (posaconazole) Oral SuspensionPosaconazole Suspension Formulation
STEGLATRO™ (ertugliflozin) TabletsErtugliflozin Formulation
STEGLUJAN™ (ertugliflozin and sitagliptin) TabletsErtugliflozin (< 2%) / Sitagliptin
Formulation
STEGLUJAN™ (ertugliflozin and sitagliptin) TabletsErtugliflozin (< 5%) / Sitagliptin
Formulation
STOCRIN® (efavirenz) Oral SolutionEfavirenz Liquid Formulation
STOCRIN® (efavirenz) Tablet for Oral UseEfavirenz Solid Formulation
STROMECTOL® (ivermectin) TabletsIvermectin Solid Formulation
SYLATRON™ (peginterferon alfa-2b) Injection, for Subcutaneous UsePeginterferon Alfa-2b
Powder Formulation
XELEVIA Met XR® (sitagliptin and metformin) Extended Release Tablet for Oral
UseSitagliptin / Metformin Extended Release Formulation
XELEVIA® (sitagliptin) Tablets for Oral UseSitagliptin Formulation
XELEZOR® (sitagliptin and simvastatin) Tablet for Oral UseSitagliptin / Simvastatin
Formulation
Z
• MerckHelps
Merck Patient Assistance Program provides certain Merck medicines and adult vaccines
for free to qualified patients
• Merck Access Program
Information about insurance coverage and financial assistance options for eligible
patients
• Clinical trials
Information about insurance coverage and financial assistance options for eligible
patients
• Merck Manuals
Medical information source covering thousands of topics in all fields of medicine
Sustainability
• Impact Report
Reporting on our commitment to operating responsibly to benefit society
• Merck for Mothers
An initiative to create a world where no woman has to die giving life
About Merck
• Merck Animal Health
The global animal health business unit of Merck
• Health Plan - Transparency in Coverage
In compliance with the Consolidated Appropriations Act, learn more about our health
plan’s pricing information
• Contact Us
If you have a question or need more information about us, find out who you should
contact.
• Forward-looking statement
• Cookie policy
• Cookie Preferences
• Privacy
• Transparency disclosure
• Terms of use
• Accessibility
• Sitemap
• Consumer Health Data Privacy Policy
• Your Privacy Choices
Copyright © 2024 Merck & Co., Inc., Rahway, NJ USA, and its affiliates. All rights reserved. | This site is
intended only for residents of the United States and Canada.